|Bid||2.6100 x 0|
|Ask||2.6400 x 0|
|Day's Range||2.5800 - 2.7650|
|52 Week Range||2.3800 - 12.0000|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 28, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for BIOVIC-B.ST
UPPSALA, SWEDEN / ACCESSWIRE / November 28, 2023 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Continued sales growth and several commercial agreements signed!SEK tQ2 23/24Q2 22/23May-Oct 23/24May-Oct 22/23Full year 22/23Net sales2,5639614,3161,5063,383Operating ...
UPPSALA, SE / ACCESSWIRE / November 24, 2023 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica, active in cancer diagnostics, publishes its interim report for the second quarter 2023/2024, on November 28 at 08:00 CET. The company ...
UPPSALA, SE / ACCESSWIRE / November 23, 2023 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) The extra general meeting of Biovica International AB (the "Company") was held today on 23 November 2023 and the following resolution was passed ...